Correction To: Effectiveness of Monthly Intravenous Ibandronate on the Low Responders to Oral Bisphosphonate: The MOVEMENT Study

Journal of Bone and Mineral Metabolism - Japan
doi 10.1007/s00774-019-01030-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Clinical Efficacy and Safety of Monthly Oral Ibandronate 100 Mg Versus Monthly Intravenous Ibandronate 1 Mg in Japanese Patients With Primary Osteoporosis

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2015English

Patient Satisfaction in Postmenopausal Women Treated With a Weekly Bisphosphonate Transitioned to Once-Monthly Ibandronate

Journal of Women's Health
Medicine
2009English

Correction To: Effectiveness of Aripiprazole Once-Monthly in Schizophrenia Patients Pretreated With Oral Aripiprazole: A 6-Month, Real-Life Non-Interventional Study

BMC Psychiatry
PsychiatryMental Health
2018English

Hypocalcaemia After Intravenous Bisphosphonate: Lesson to Be Learnt

BMJ
2004English

Correction To: The Black Campus Movement

2015English

Plasma C-Peptide Response to Oral Glucose in Low Insulin Responders, Subdiabetic, and Diabetic Subjects

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
1977English

Oral Ulcers Suspected to Be Caused by Improper Administration of Bisphosphonate

Japanese Journal of Oral and Maxillofacial Surgery
2019English

PMS57 Effect of Different Methods on Estimating Persistence to Oral Bisphosphonate Therapy in Portuguese PMO Patients – An Observational Prospective Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Hypersensitivity Reaction to Intravenous but Not Oral Tacrolimus

Transplantation
Transplantation
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy